VERA
Vera Therapeutics Inc
NASDAQ: VERA · HEALTHCARE · BIOTECHNOLOGY
$35.84
-3.42% today
Updated 2026-04-29
Market cap
$2.57B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.66
Dividend yield
—
52W range
$19 – $56
Volume
1.2M
Vera Therapeutics Inc (VERA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-17.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-93.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.2%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-5.9%
2025-08-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $-1.39 | -8.6% | $38.32 | $40.53 | +5.8% |
| 2025-11-05 | $-1.26 | -9.6% | $24.35 | $25.22 | +3.6% |
| 2025-08-05 | $-1.20 | -46.3% | $20.45 | $19.25 | -5.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.28 | $-1.39 | -8.6% | — | — |
| 2025-09-30 | $-1.15 | $-1.26 | -9.6% | — | — |
| 2025-06-30 | $-0.82 | $-1.20 | -46.3% | — | — |
| 2025-03-31 | $-0.78 | $-0.81 | -4.2% | — | — |
| 2024-12-31 | $-0.81 | $-0.72 | +11.1% | — | — |
| 2024-09-30 | $-0.64 | $-0.85 | -33.3% | — | — |
| 2024-06-30 | $-0.56 | $-0.62 | -10.7% | — | — |
| 2024-03-31 | $-0.53 | $-0.56 | -5.7% | — | — |
| 2023-12-31 | $-0.51 | $-0.60 | -17.6% | — | — |
| 2023-09-30 | $-0.53 | $-0.45 | +15.1% | — | — |
| 2023-06-30 | $-0.69 | $-0.46 | +33.3% | — | — |
Frequently asked questions
Has Vera Therapeutics Inc beaten earnings estimates?
Vera Therapeutics Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -17.2% over the last 4 quarters.
How does VERA stock react to earnings?
VERA stock has moved an average of +1.2% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.